Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraventricular Methotrexate with Topotecan and Cyclophosphamide in Pediatric Brain Tumors
NCT02684071Phase 2Terminated
- Sponsor
- Nicklaus Children's Hospital
- Start
- Feb 2016
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate in medulloblastoma, ependymoma, Atypical teratoid rhabdoid tumor (ATRT), primitive neuroectodermal tumor (PNET), sponsored by Nicklaus Children's Hospital. Started Feb 2016; status: terminated.
02
Drugs
methotrexate
03
Conditions
medulloblastomaependymomaAtypical teratoid rhabdoid tumor (ATRT)primitive neuroectodermal tumor (PNET)
Beyond the preview
Go deeper on NCT02684071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02684071.